Ul Hosts New €5m Pharmaceutical Manufacturing Technology Centre
The Minister for Skills, Research and Innovation, Damien English TD, recently launched the Pharmaceutical Manufacturing Technology Centre (PMTC) which will be headquartered at the University of Limerick. The State, through the Department of Jobs, Enterprise & Innovation, is investing €5M over the next 5 years in this industry-focussed Centre which will deliver advanced technology solutions to contemporary manufacturing issues currently challenging the Irish pharmaceutical sector. PMTC is the latest of 15 state-supported Technology Centres established jointly by Enterprise Ireland and IDA Ireland. The Centre brings together 24 industry partners and 9 Higher Education Institutes who will deliver the research.
The aim of PMTC is to make Ireland the global hub of pharmaceutical process innovation and manufacturing and ultimately support an industry which directly employs over 25,000 people. Manufacturing cost competitiveness and patent expiry are among the two most critical issues which threaten the future of this industry which contributes over €40BN in Irish exports per annum. The industry consortium currently comprises a mix of indigenous multinational pharmaceutical companies and SME’s including: Alkermes, Allergan Pharmaceutical, Applied Process Consulting, Astellas, Bristol-Myers Squibb Swords, Crest Solutions, Eli Lilly, Gilead, GSK, Helsinn Birex, Innopharma Labs, Janssen, Label Art, Leo Pharma, Merck Sharp Dohme, Pfizer, Process Analytics, Roche, Servier, Sigmoid Pharma, Takeda Pharmaceuticals, Techno-Path, Teva Pharmaceuticals and TopChem Pharma.
Pictured above are: Dr Chris Edlin, Director, PMTC, Minister Damien English, Dr Mary Shire, Vice President Research, UL, Professor Gavin Walker, Bernal Chair of Pharmaceutical Powder Engineering, UL and PMTC Research Team